FDA approves Trulicity to treat type 2 diabetes
September 18, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm415180.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
Leggi
Giallo
Le Breaking News di colore giallo sono relative a notizie dalle agenzie regolatorie o da società scientifiche: nuovi farmaci, ritiri, eventi avversi rilevanti…
FDA approves weight-management drug Contrave
September 10, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm413896.htm
Leggi
Cardiovascular Disease Risk Factors in Youth With Diabetes Mellitus: A Scientific Statement From the American Heart Association
David M. Maahs, Stephen R. Daniels, Sarah D. de Ferranti Circulation. published online August 28, 2014 http://circ.ahajournals.org/content/early/2014/08/28/CIR.0000000000000094
Leggi
AIFA – Nuove modalità compilazione Piano Terapeutico Incretine
(03/09/2014) http://www.agenziafarmaco.gov.it/it/content/nuove-modalit%C3%A0-compilazione-piano-terapeutico-incretine-03092014
Leggi
FDA approves Jardiance to treat type 2 diabetes
FDA News Release - August 1, 2014 http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm407637.htm
Leggi
CHMP summary of positive opinion for Xultophy
http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002647/WC500170171.pdf
Leggi
Xultophy
European Medicines Agency, 25/07/2014 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002647/smops/Positive/human_smop_000714.jsp&mid=WC0b01ac058001d127
Leggi
L’uso dei farmaci in Italia – Rapporto OsMed 2013
http://www.agenziafarmaco.gov.it/it/content/luso-dei-farmaci-italia-rapporto-osmed-2013
Leggi
Confidentiality of Interim Results in Cardiovascular Outcome Safety Trials; Public Hearing; Request for Comments
A Proposed Rule by the Food and Drug Administration on 07/15/2014 https://s3.amazonaws.com/public-inspection.federalregister.gov/2014-16374.pdf
Leggi
FDA approves Afrezza (insulin human) Inhalation Powder to treat diabetes
FDA News Release, June 27, 2014 http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm403122.htm
Leggi